David A Ramsay - Net Worth and Insider Trading

David A Ramsay Net Worth

The estimated net worth of David A Ramsay is at least $11 Million dollars as of 2024-04-20. David A Ramsay is the Director of Savara Inc and owns about 2,201,142 shares of Savara Inc (SVRA) stock worth over $11 Million. David A Ramsay is also the Director of La Jolla Pharmaceutical Co and owns about 100,000 shares of La Jolla Pharmaceutical Co (LJPC) stock worth over $622,000. Details can be seen in David A Ramsay's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David A Ramsay has not made any transactions after 2023-05-26 and currently still holds the listed stock(s).

Transaction Summary of David A Ramsay

To

David A Ramsay Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David A Ramsay owns 3 companies in total, including La Jolla Pharmaceutical Co (LJPC) , Savara Inc (SVRA) , and Halozyme Therapeutics Inc (HALO) .

Click here to see the complete history of David A Ramsay’s form 4 insider trades.

Insider Ownership Summary of David A Ramsay

Ticker Comapny Transaction Date Type of Owner
LJPC La Jolla Pharmaceutical Co 2022-08-22 director
SVRA Savara Inc 2023-05-26 director
HALO Halozyme Therapeutics Inc 2004-03-11 Vice President & CFO

David A Ramsay Latest Holdings Summary

David A Ramsay currently owns a total of 2 stocks. Among these stocks, David A Ramsay owns 2,201,142 shares of Savara Inc (SVRA) as of May 26, 2023, with a value of $11 Million and a weighting of 94.45%. David A Ramsay also owns 100,000 shares of La Jolla Pharmaceutical Co (LJPC) as of December 6, 2021, with a value of $622,000 and a weighting of 5.55%.

Latest Holdings of David A Ramsay

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SVRA Savara Inc 2023-05-26 2,201,142 4.81 10,587,493
LJPC La Jolla Pharmaceutical Co 2021-12-06 100,000 6.22 622,000

Holding Weightings of David A Ramsay


David A Ramsay Form 4 Trading Tracker

According to the SEC Form 4 filings, David A Ramsay has made a total of 24 transactions in Savara Inc (SVRA) over the past 5 years, including 24 buys and 0 sells. The most-recent trade in Savara Inc is the acquisition of 100,000 shares on May 26, 2023, which cost David A Ramsay around $259,000.

According to the SEC Form 4 filings, David A Ramsay has made a total of 4 transactions in La Jolla Pharmaceutical Co (LJPC) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in La Jolla Pharmaceutical Co is the acquisition of 24,500 shares on December 6, 2021, which cost David A Ramsay around $91,875.

Insider Trading History of David A Ramsay

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David A Ramsay Trading Performance

GuruFocus tracks the stock performance after each of David A Ramsay's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David A Ramsay is 14.45%. GuruFocus also compares David A Ramsay's trading performance to market benchmark return within the same time period. The performance of stocks bought by David A Ramsay within 3 months outperforms 22 times out of 29 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how David A Ramsay's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of David A Ramsay

Average Return

80.49%

Average return per transaction

Outperforming Transactions

92%

24 out of 26 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 10.5 14.45 33.65 80.49 57.22 -3.83
Relative Return to S&P 500(%) 9.86 13.82 32.4 74.99 53.45 -12.69

David A Ramsay Ownership Network

Ownership Network List of David A Ramsay

No Data

Ownership Network Relation of David A Ramsay


David A Ramsay Owned Company Details

What does La Jolla Pharmaceutical Co do?

Who are the key executives at La Jolla Pharmaceutical Co?

David A Ramsay is the director of La Jolla Pharmaceutical Co. Other key executives at La Jolla Pharmaceutical Co include director & 10 percent owner Kevin C Tang , director & Chief Executive Officer Larry G. Edwards , and Chief Financial Officer Michael S Hearne .

La Jolla Pharmaceutical Co (LJPC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of La Jolla Pharmaceutical Co (LJPC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of La Jolla Pharmaceutical Co (LJPC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

La Jolla Pharmaceutical Co (LJPC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

La Jolla Pharmaceutical Co Insider Transactions

No Available Data

David A Ramsay Mailing Address

Above is the net worth, insider trading, and ownership report for David A Ramsay. You might contact David A Ramsay via mailing address: Halozyme Therapeutics, Inc., 11588 Sorrento Valley Road, #17, San Diego Ca 92121.

Discussions on David A Ramsay

No discussions yet.